English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background —β-Blockers are the first line of therapy for hypertension. However, they are associated with side effects because of central nervous system (CNS) effects and β2 -adrenergic antagonism. To overcome these problems and provide a long-term β1 -blockade, antisense oligonucleotides against rat β1 -adrenergic receptor (β1 -AR) mRNA (β1 -AS-ODN) were designed and tested for the ability to inhibit cardiac β1 -ARs as well as lower blood pressure in spontaneously hypertensive rats (SHRs).Methods and Results —Radioligand binding assay showed that a single intravenous injection of β1 -AS-ODN delivered in cationic liposomes significantly decreased cardiac β1 -AR density by 30% to 50% for 18 days (P &lt;0.01), with no effect on β2 -ARs. This was accompanied by marked attenuation of β1 -AR–mediated positive inotropic response in isolated perfused hearts in vitro (P &lt;0.02) and in conscious SHRs monitored by telemetry in vivo (P &lt;0.02). Furthermore, the blood pressure of SHRs was reduced for 20 days, with a 38 mm Hg maximum drop. Heart rate was not significantly decreased. Quantitative autoradiography was performed to assess β1 -AS-ODN effects on the CNS, which demonstrated no changes in β1 -ARs in brain, in contrast to a significant reduction in heart and kidney (P &lt;0.05). For comparison with β-blockers, the effects of atenolol on cardiovascular hemodynamics were examined, which lowered blood pressure for only 10 hours and elicited appreciable bradycardia in SHRs.Conclusions —These results indicate that β1 -AS-ODN, a novel approach to specific β1 -blockade, has advantages over currently used β-blockers in providing a profound and prolonged reduction in blood pressure without affecting heart rate, β2 -ARs, and the CNS. Diminished cardiac contractility resulting from less β1 -AR expression contributes to the antihypertensive effect.

circulation

Antisense Inhibition of β <sub>1</sub> -Adrenergic Receptor mRNA in a Single Dose Produces a Profound and Prolonged Reduction in High Blood Pressure in Spontaneously Hypertensive Rats

Antisense Inhibition of β 1 -Adrenergic Receptor mRNA in a Single Dose Produces a Profound and Prolonged Reduction in High Blood Pressure in Spontaneously Hypertensive Rats

Antisense Inhibition of β ₁ -Adrenergic Receptor mRNA in a Single Dose Produces a Profound and Prolonged Reduction in High Blood Pressure in Spontaneously Hypertensive Rats